Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 118321
Published online Sep 9, 2026. doi: 10.5409/wjcp.118321
Published online Sep 9, 2026. doi: 10.5409/wjcp.118321
Table 2 Primary outcome and clinical parameters 48 hours post-procedure, n (%)
| GA | TA | P value | |
| Episodes of apnea | 3 (16.6) | 1(5.6) | 0.601 |
| Need for oxygen 48 hours post-procedure | 5 (27.8) | 1 (5.6) | 0.177 |
| Need for respiratory support 48 hours post procedure | 5 (27.8) | 0 (0.0) | 0.045 |
| RR (breath/minute), mean (SD) | 42.5 (10.8) | 47 (6.7) | 0.187 |
| HR (beat/minute), mean (SD) | 144.8 (9.0) | 150 (10.1) | 0.771 |
| Syst. p(B) (mmHg), mean (SD) | 80.3 (7.5) | 77.9 (13.6) | 0.046 |
| Dia. P(B) (mmHg), mean (SD) | 41.3 (5.9) | 50 (17.3) | 0.001 |
| Oxygen saturation (%), mean (SD) | 98.4 (2.1) | 96.8 (2.5) | 0.443 |
- Citation: Al Habsi AA, Al Mandhari HK, Ganesh AS, Al Zuhaibi SS, Al Habsi NS, Al-Farsi NH. Systemic outcomes of anesthesia method in anti-vascular endothelial growth factor therapy for retinopathy of prematurity: General vs topical. World J Clin Pediatr 2026; 15(3): 118321
- URL: https://www.wjgnet.com/2219-2808/full/v15/i3/118321.htm
- DOI: https://dx.doi.org/10.5409/wjcp.118321